Skip to content
2000
Volume 23, Issue 29
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults with intensive heterogeneity and one of the most lethal human cancers. Protein kinases control diverse cellular processes by coordinating different signaling pathways. Protein kinases are frequently dysregulated in human cancers, which contributes to tumor initiation and development. Thus, protein kinases are a growing drug target class for cancers including glioblastoma. This review focuses on the most important protein kinases and kinase-mediated signaling cascades in glioblastoma, and discusses the functional mechanism of these kinases in glioblastoma tumorigenesis. Moreover, this review has summarized the most recent preclinical and clinical advances of agents targeting protein kinases in the treatment of glioblastoma.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612823666170710144325
2017-08-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612823666170710144325
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test